Consumer Discretionary • Specialty Chemicals
$1.85 ▼ -0.01
(-0.54%)
MKT CAP: $41.0M • VOL: 7.8K
52W L $1 52W H $22
ROARABLE / RQD
D- • 35/100
PIOTROSKI
3 / 9
NPT // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-06-30 | FY 2024
FILED 2024-06-30 | FY 2023
FILED 2023-06-30 |
|---|---|---|---|
| Revenue (Total Sales) | $797.1M | $672.7M | $552.5M |
| YoY Revenue Growth % | +18.5% | +21.7% | — |
| Gross Profit | $4.7M | $4.8M | — |
| Gross Margin % | 0.6% | 0.7% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$600.6K | $660.0K | $1.3M |
| Operating Margin % | -0.1% | 0.1% | 0.2% |
| Net Income (GAAP) | -$932.6K | $953.6K | $2.0M |
| EBITDA (Normalized) | $35.5M | $27.3M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $2.3M | -$30.8M | -$14.2M |
| Capital Expenditures (CapEx) | $45.1M | $33.3M | — |
| Free Cash Flow (FCF) | -$42.8M | -$64.1M | -$14.2M |
| FCF Margin % | -5.4% | -9.5% | -2.6% |
| Return on Invested Capital (ROIC %) | — | — | — |
| Cash & Short-Term Equivalents | — | — | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | — | — | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR NPT.